Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
45 /100
MEDIUM RISK
Score updated Aug 28, 2026

IOVA — Iovance Biotherapeutics, Inc. Dilution Risk Tracker

Track IOVA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IOVA — Get alerts when the score changes →

As of August 28, 2026, Iovance Biotherapeutics, Inc. (IOVA) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Iovance Biotherapeutics, Inc. has a market capitalization of $1.83B, 452.97M shares outstanding, 289 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track IOVA — Get forecast alerts →

Market Data

Market Cap$1.83B
Shares Outstanding452.97M
Float387.98M
Cash$297.67M
Debt$47.78M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 18.6% shares (2026Q1 vs prior)
289 institutional holders · 325.19M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 33.24M shares
#2 BlackRock, Inc. 31.08M shares
#3 MHR FUND MANAGEMENT LLC 28.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest99.98M
Days to Cover6.3
% of Float25.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2018-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IOVA Dilution Snapshot

Iovance Biotherapeutics, Inc. (IOVA) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IOVA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IOVA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IOVA
IOVA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.